Effectiveness of percutaneous coronary intervention within 12 hours to 28 days of ST-elevation myocardial infarction in a real-world Chinese population.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 3595272)

Published in PLoS One on March 12, 2013

Authors

Xingli Wu1, Dingyou Yang, Yusheng Zhao, Caiyi Lu, Yu Wang

Author Affiliations

1: Institute of Geriatric Cardiology, China PLA General Hospital, Beijing, China. WXL301@yahoo.com

Articles cited by this

Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation (2009) 27.89

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet (2003) 19.90

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J (2011) 13.10

Coronary intervention for persistent occlusion after myocardial infarction. N Engl J Med (2006) 8.74

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35

Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med (2009) 6.18

Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep (2004) 3.84

Impact of National Clinical Guideline recommendations for revascularization of persistently occluded infarct-related arteries on clinical practice in the United States. Arch Intern Med (2011) 3.73

Outcome of elderly patients with chronic symptomatic coronary artery disease with an invasive vs optimized medical treatment strategy: one-year results of the randomized TIME trial. JAMA (2003) 3.40

Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA (2005) 2.56

Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA (2006) 2.35

Reperfusion therapy in elderly patients with acute myocardial infarction: a randomized comparison of primary angioplasty and thrombolytic therapy. J Am Coll Cardiol (2002) 2.13

Contemporary outcome trends in the elderly undergoing percutaneous coronary interventions: results in 7,472 octogenarians. National Cardiovascular Network Collaboration. J Am Coll Cardiol (2000) 2.12

ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation (2004) 1.81

Incidence of and outcomes associated with ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention. JAMA (2009) 1.80

Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med (2010) 1.62

Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20,290 patients from the AMIS Plus Registry. Heart (2007) 1.55

Delayed post-myocardial infarction invasive measures, helpful or harmful? A subgroup analysis. Chest (2004) 1.51

Management of acute myocardial infarction in the real world: a summary report from The Ami-Florence Italian Registry. Intern Emerg Med (2008) 1.48

Myocardial infarction and the open-artery hypothesis. N Engl J Med (2006) 1.46

Long-term mortality after PCI in patients with diabetes mellitus: results from the Swedish Coronary Angiography and Angioplasty Registry. EuroIntervention (2010) 1.45

Female gender is an independent predictor of in-hospital mortality after STEMI in the era of primary PCI: insights from the greater Paris area PCI Registry. EuroIntervention (2011) 1.44

An evaluation of octogenarians undergoing percutaneous coronary intervention from the Melbourne Interventional Group registry. Catheter Cardiovasc Interv (2007) 1.29

Multicenter experience in revascularization of very elderly patients. Am Heart J (2004) 1.15

Continued benefit of coronary stenting versus balloon angioplasty: five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol (2001) 1.15

Long-term impact of chronic kidney disease in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial. JACC Cardiovasc Interv (2011) 1.08

Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial). Am J Cardiol (2010) 1.04

Revision of the multiple organ failure score. Langenbecks Arch Surg (2002) 1.02

Percutaneous coronary interventions in octogenarians in the American College of Cardiology-National Cardiovascular Data Registry: development of a nomogram predictive of in-hospital mortality. J Am Coll Cardiol (2002) 1.02

Primary percutaneous coronary intervention for every patient with ST-segment elevation myocardial infarction: what stands in the way? Ann Intern Med (2004) 0.98

Impact of age on treatment and outcomes in ST-elevation myocardial infarction. Am Heart J (2011) 0.98

Temporal trends in gastrointestinal bleeding associated with percutaneous coronary intervention: analysis of the 1998-2006 Nationwide Inpatient Sample (NIS) database. Am Heart J (2011) 0.94

Predictors of outcome after percutaneous treatment for cardiogenic shock. Heart (2005) 0.93

Gender-based differences in long-term outcome after ST-elevation myocardial infarction in patients treated with percutaneous coronary intervention. J Womens Health (Larchmt) (2010) 0.87

The prognostic value of atrial fibrillation on 30-day clinical outcome in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Int Heart J (2011) 0.86

Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service. Am Heart J (2010) 0.85

Effectiveness and safety of routine primary angioplasty in patients aged > or =85 years with acute myocardial infarction. Circ J (2008) 0.84

Impact of hypertension on short- and long-term prognoses in patients with ST elevation myocardial infarction and without previously known diabetes. Heart Vessels (2011) 0.83

Prevalence of major infections and adverse outcomes among hospitalized. ST-elevation myocardial infarction patients in Florida, 2006. BMC Cardiovasc Disord (2011) 0.83

Predictors of 30-day and 1-year mortality after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Coron Artery Dis (2009) 0.82

Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction. Ann Intern Med (2006) 0.81

Prognosis and outcomes of elderly (75-84 years) patients with acute myocardial infarction 1-2 years after the event: AMI-elderly study of the MONICA/KORA Myocardial Infarction Registry. Int J Cardiol (2010) 0.81

[Mortality of patients who are older than 75 years after ST elevation myocardial infarction in clinical practice]. Dtsch Med Wochenschr (2005) 0.80

[STEMI network Essen-in-hospital results]. Herz (2008) 0.79

Revascularization algorithm in acute STEMI should take into account age. Cardiovasc Revasc Med (2007) 0.78

Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h. Eur Heart J (2009) 0.78

Ischaemic stroke complicating primary percutaneous coronary intervention in patients with ST elevation myocardial infarction. Acta Cardiol (2009) 0.77

Percutaneous transluminal coronary angioplasty in the elderly. Clin Geriatr Med (1996) 0.76

The optimal time of elective percutaneous coronary intervention for stable patients after ST elevation myocardial infarction. Angiology (2008) 0.76

Articles by these authors

(truncated to the top 100)

Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med (2013) 24.88

The Sorghum bicolor genome and the diversification of grasses. Nature (2009) 14.62

Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18

Complete MHC haplotype sequencing for common disease gene mapping. Genome Res (2004) 12.09

A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet (2008) 8.44

Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet (2013) 7.70

Epidemiology of human infections with avian influenza A(H7N9) virus in China. N Engl J Med (2013) 7.52

Evolution of China's response to HIV/AIDS. Lancet (2007) 7.34

A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med (2006) 6.86

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30

National survey of drug-resistant tuberculosis in China. N Engl J Med (2012) 6.28

Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet (2013) 6.10

Emergence and control of infectious diseases in China. Lancet (2008) 5.93

Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat Genet (2011) 5.62

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest (2003) 5.32

Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA (2008) 5.01

Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res (2002) 4.92

Coordinated regulation of Arabidopsis thaliana development by light and gibberellins. Nature (2008) 4.71

Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet (2006) 4.22

Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet (2009) 3.97

Human infection with avian influenza A H7N9 virus: an assessment of clinical severity. Lancet (2013) 3.90

An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China. Virol J (2010) 3.90

Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci U S A (2011) 3.80

Comparative epidemiology of human infections with avian influenza A H7N9 and H5N1 viruses in China: a population-based study of laboratory-confirmed cases. Lancet (2013) 3.77

Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis (2011) 3.73

Human Streptococcus suis outbreak, Sichuan, China. Emerg Infect Dis (2006) 3.65

Genome dynamics and diversity of Shigella species, the etiologic agents of bacillary dysentery. Nucleic Acids Res (2005) 3.56

The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem (2007) 3.38

Biological features of novel avian influenza A (H7N9) virus. Nature (2013) 3.24

Temporal relationship and predictive value of urinary acute kidney injury biomarkers after pediatric cardiopulmonary bypass. J Am Coll Cardiol (2011) 3.17

Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med (2006) 2.99

Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction. Circ Res (2003) 2.85

Synthesis of N-doped graphene by chemical vapor deposition and its electrical properties. Nano Lett (2009) 2.85

Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann Neurol (2011) 2.84

Retracted An endogenous, systemic RNAi pathway in plants. EMBO J (2010) 2.82

The Chinese free antiretroviral treatment program: challenges and responses. AIDS (2007) 2.73

Angiopoietin-like protein 4 decreases blood glucose and improves glucose tolerance but induces hyperlipidemia and hepatic steatosis in mice. Proc Natl Acad Sci U S A (2005) 2.63

Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome. Clin Chem (2006) 2.63

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis (2009) 2.62

Identification and control of a poliomyelitis outbreak in Xinjiang, China. N Engl J Med (2013) 2.55

Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab (2013) 2.49

Colloids with valence and specific directional bonding. Nature (2012) 2.49

DCDC2 is associated with reading disability and modulates neuronal development in the brain. Proc Natl Acad Sci U S A (2005) 2.35

Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science (2013) 2.34

ProfCom: a web tool for profiling the complex functionality of gene groups identified from high-throughput data. Nucleic Acids Res (2008) 2.33

Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study. Circulation (2007) 2.29

Clinical characteristics of 26 human cases of highly pathogenic avian influenza A (H5N1) virus infection in China. PLoS One (2008) 2.28

Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem (2005) 2.28

HIV and syphilis prevalence among men who have sex with men: a cross-sectional survey of 61 cities in China. Clin Infect Dis (2013) 2.24

SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res (2010) 2.20

Elucidation of CXCR7-mediated signaling events and inhibition of CXCR4-mediated tumor cell transendothelial migration by CXCR7 ligands. J Immunol (2009) 2.19

CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. Blood (2012) 2.18

The chromosome 6p22 haplotype associated with dyslexia reduces the expression of KIAA0319, a novel gene involved in neuronal migration. Hum Mol Genet (2006) 2.14

No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects. Breast Cancer Res Treat (2010) 2.12

Concern Misregulation of AUXIN RESPONSE FACTOR 8 underlies the developmental abnormalities caused by three distinct viral silencing suppressors in Arabidopsis. PLoS Pathog (2011) 2.12

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo. Cancer Res (2002) 2.09

Retracted Randomized clinical trial of arginine-supplemented enteral nutrition versus standard enteral nutrition in patients undergoing gastric cancer surgery. J Cancer Res Clin Oncol (2013) 2.08

Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes (2007) 2.08

Streptococcus suis sequence type 7 outbreak, Sichuan, China. Emerg Infect Dis (2006) 2.07

Myelopathy due to calcified meningiomas of the thoracic spine: minimum 3-year follow-up after surgical treatment. J Neurosurg Spine (2013) 2.02

Hydrogen clusters in clathrate hydrate. Science (2002) 2.00

Estimating the number of people living with HIV/AIDS in China: 2003-09. Int J Epidemiol (2010) 1.96

Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells. J Immunol (2006) 1.90

Serum adipocyte fatty acid binding protein as a new biomarker predicting the development of type 2 diabetes: a 10-year prospective study in a Chinese cohort. Diabetes Care (2007) 1.88

Risk factors for severe illness with 2009 pandemic influenza A (H1N1) virus infection in China. Clin Infect Dis (2011) 1.87

Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85

Morphology-tuned wurtzite-type ZnS nanobelts. Nat Mater (2005) 1.84

Oxytocin deficiency mediates hyperphagic obesity of Sim1 haploinsufficient mice. Mol Endocrinol (2008) 1.83

Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice. Hepatology (2014) 1.80

Diverse set of microRNAs are responsive to powdery mildew infection and heat stress in wheat (Triticum aestivum L.). BMC Plant Biol (2010) 1.80

1B50-1, a mAb raised against recurrent tumor cells, targets liver tumor-initiating cells by binding to the calcium channel α2δ1 subunit. Cancer Cell (2013) 1.79

The first confirmed human case of avian influenza A (H5N1) in Mainland China. Lancet (2006) 1.79

Organization of the Caenorhabditis elegans small non-coding transcriptome: genomic features, biogenesis, and expression. Genome Res (2005) 1.77

Generation of human induced pluripotent stem cells from urine samples. Nat Protoc (2012) 1.76

[The epidemic characteristics and preventive measures of hemorrhagic fever with syndromes in China]. Zhonghua Liu Xing Bing Xue Za Zhi (2004) 1.71

Lipocalin-2 deficiency attenuates insulin resistance associated with aging and obesity. Diabetes (2010) 1.71

Human influenza A (H5N1) cases, urban areas of People's Republic of China, 2005-2006. Emerg Infect Dis (2007) 1.71

MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum (2011) 1.71

Deep-sequencing of plant viral small RNAs reveals effective and widespread targeting of viral genomes. Virology (2009) 1.70

Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PLoS One (2013) 1.67

Surveillance of hand, foot, and mouth disease in mainland China (2008-2009). Biomed Environ Sci (2011) 1.67

Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass. J Pediatr (2011) 1.66

Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells. Gene (2012) 1.64

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China. BMJ (2010) 1.64

Two evolutionary histories in the genome of rice: the roles of domestication genes. PLoS Genet (2011) 1.63

Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma. AJR Am J Roentgenol (2006) 1.62

[Effects of different tillage methods and straw-returning on soil organic carbon content in a winter wheat field]. Ying Yong Sheng Tai Xue Bao (2010) 1.61

Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood (2012) 1.61

Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J Cell Sci (2008) 1.61

Wearable sensors and telerehabilitation. IEEE Eng Med Biol Mag (2003) 1.60

Vibrational spectra of phenyltriethoxysilane, phenyltrimethoxysilane and their sol-gels. Spectrochim Acta A Mol Biomol Spectrosc (2008) 1.60

Dominant B cell epitope from NY-ESO-1 recognized by sera from a wide spectrum of cancer patients: implications as a potential biomarker. Int J Cancer (2005) 1.59

Prenatal exposure to mercury and neurobehavioral development of neonates in Zhoushan City, China. Environ Res (2007) 1.58

Identification of New Delhi metallo-β-lactamase 1 in Acinetobacter lwoffii of food animal origin. PLoS One (2012) 1.58

Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat Genet (2013) 1.57

HIGH-RESOLUTION L(Y)SO DETECTORS USING PMT-QUADRANT-SHARING FOR HUMAN & ANIMAL PET CAMERAS. IEEE Trans Nucl Sci (2008) 1.56

Solution structure of monomeric BsaL, the type III secretion needle protein of Burkholderia pseudomallei. J Mol Biol (2006) 1.55

Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res (2011) 1.55

The seroprevalence of pandemic influenza H1N1 (2009) virus in China. PLoS One (2011) 1.54